Achilles Tendon Lengthening in Diabetic
Neuropathic Osteoarthropathy - Charcot Foot


Brian Richman, DPM *


* Active Staff Podiatrist, Davis Hospital and Medical Center, Layton, Utah. McKay-Dee Hospital Ogden, Utah. Logan Regional Hospital, Logan, Utah. Private Practice Mailing Address: 1660 West Antelope Drive # 110 Layton, Utah 84041. Web Site: www.DrBrianRichman.com

Author's note: This is the first article in a series of three on diabetic foot care. TAL in
Diabetic Neuropathic Osteoarthropathy - Charcot Foot, Surgical Approach to Diabetic Foot
Ulcers, and Diabetic Puncture Wounds. New and exciting break through events are happening in the surgical treatment of the diabetic foot. I believe that these three articles will have some value that will help prevent many diabetic foot problems.

The views and opinions expressed in these journal articles are the sole responsibility of the
author and should not be considered standard of care.


Abstract

The achilles tendon has a strong plantarflexory force that contributes to the breakdown of active charcot foot. By performing a achilles tendon lengthening or weakening procedure it helps eliminate the destructive forces in the charcot process. When you decrease the destructive forces in active charcot disease, you eliminate the further collapsing and breakdown of the foot and ankle. You also prevent rocker bottom deformity, ulceration, infection, and amputation.

Within the last couple of years, the author has had eight diabetic patients with active charcot foot with midfoot bone and joint destruction. All eight patients had a achilles tendon lenghtening/weakening procedure which stopped the collapsing and further destructive forces from occurring in their foot.


Introduction

For many years, doctors have been aware of the seriousness of the complications associated with diabetic neuropathic osteoarthropathy or charcot foot. Ulceration, infection, foot deformities, delayed healing, amputation, rocker bottom deformity and chronic wounds are all potential problems in the diabetic foot, but especially dangerous in charcot disease. Avoiding complications and preventing this disease from progressing has been a long term goal of many physicians.

Charcot foot has been described in three phases - development, coalescence, and reconstruction. Acute or atrophic (destructive) phase is the most dangerous and destroys normal foot and ankle anatomy. The acute phase of neuroarthropathy is often precipitated by minor trauma and is characterized by swelling, local heat, erythema, laxity of ligaments, joint effusion, and bone resorption. (1) Weight bearing of the affected foot can cause increased bone destruction, subluxations, and ulceration with a rocker bottom foot deformity. Chronic or hypertrophic (coalescence and reconstruction) phase is where the body tries to repair the damage done from the destructive phase. Usually the damage is done by the time the charcot foot enters the chronic or hypertrophic phase.

The achilles tendon is the strongest and thickest of all the tendons in the body. (2) It forms the common insertion of the gastrocnemius and soleus muscles or the triceps surae muscles and originates about 6 inches (15 cm) above the calcaneous. (3) The tendo calcaneus or achilles tendon is a major plantarflexory force through the midfoot and hind foot. The soleus and gastrocnemius are powerful plantar flexors of the ankle joint. (4)


A Case Report

A 57 IDDM male who works as a baker complains of a painful Right foot x 3 weeks. States that he works on concrete 8 to 10 hours per day. States his family practitioner thought he had Cellulitis and has been on antibiotics x 2 weeks. Denies any fever. States that his foot still hurts to walk.

Past Medical History - IDDM x 20 years, HTN, CAD, Hypothyroid, Asthma, Arthritis, Low Back Pain, Peripherial Neuropathy, Allergies, Hayfever.

Past surgical history - Heart Bypass, L shoulder surgery, gallbladder removal.

Medications - Prozac, Insulin, Levothyroxin. Allergies - NKDA.

On exam - the patient has swelling and pain Right midfoot and ankle area. Slight erythema R foot noted. Pain upon palpation R midfoot Lis Franc's area. No red streaking up foot or leg. Slight tightness R achilles tendon on knee extension. X-rays show bone destruction Right Lis Franc's area ( See Figures 1-3 ).

figure 1 Figure 2 Figure 3
Figure 1 Figure 2 Figure 3

Assessment - IDDM. Charcot Foot. Patient would benefit from an achilles tendon lengthening procedure to reduce the destructive charcot forces. Patient needs to find a job that does not require so much walking, standing, working on concrete.

A Right percutaneous achilles tendon lengthening procedure was performed using two small incisions. The Patient had a weight bearing fiberglass cast applied. He was given crutches and a bone stimulator to help reduce the destructive forces from charcot foot.

The surgical Goal of the percutaneous achilles tendon lengthening procedure includes Limb Salvage, preserving function, and to reduce the destructive forces on the Midfoot and ankle. Patient can not be non weight bearing. The patient needs to change employment to reduce standing, lifting, walking forces. ( patients with charcot foot needs to slowed down as much as possible.) If I suspect that a patient has charcot foot I will perform the achilles tendon lengthening procedure as soon as I can, this helps reduce the strong plantarflexory force from the achilles tendon. Allowing the patient to be non weight bearing without performing the percutaneous achilles tendon lengthening procedure will still cause charcot destruction, because you still have a strong plantarflexory force present on the midfoot and ankle.


Summary

The author presents a new procedural technique of weakening the achilles tendon for helping eliminate destructive plantarflexory forces in diabetic neuropathic osteoarthropathy. Performing an Achilles Tendon Lengthening procedure and/or an achilles tendon release procedure helps prevent further destruction of the active charcot disease process and reduces the risk of more severe complications like ulceration, infection, and amputation. Patients are still able to ambulate without serious side effects associated with active charcot foot.


Acknowledgment: Marva Myler Jensen, MEd, for her contributions to this manuscript.


References:

  1. Frykberg R: The High Risk Foot in Diabetes Mellitus, Churchill Livingstone, London, 1991,
    pp 300.

  2. Williams PL, Warwick R: Gray's anatomy, ed 36. Philadelphia, W.B. Saunders, 1980, pp 405, 604-606, 729-735, 1111-1115.

  3. Hollinshead WH: Anatomy for Surgeons: The Back and Limbs, ed 3. New York, Harper & Row, 1982, vol 3, pp 720-725, 758-759, 773-778, 783-790, 792-794.

  4. Draves D: Anatomy of the Lower Extremity, Williams and Wilkins, Baltimore, MD, 1986, pp
    264.

© 2002, Dr. Richman, All Rights Reserved